MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity
VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) — MEDBRIGHT AI INVESTMENTS INC. (CSE: MBAI; OTCQB:MBAIF; FSE: 1V7) (“MedBright” or the “Company”) announces that it has been requested by OTC Markets Group Inc. (“OTC Markets”) to issue this statement about promotional activity concerning its common shares traded on the OTCQB market (operated by OTC Markets).
Related news for (MBAIF)
- MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
- MedBright AI Issues Clarifying News Release on Continuous Disclosure Record
- MedBright AI Announces Strategic Acquisition by Numinus Wellness
- Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
- Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations